BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pawlik P, Błochowiak K. The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer's Disease and Parkinson's Disease. Diagnostics (Basel) 2021;11:371. [PMID: 33671562 DOI: 10.3390/diagnostics11020371] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Steliou K, Tamvakopoulos C, Vavvas DG, Zamboni RJ, Sampani K. Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochem Pharmacol 2021;193:114809. [PMID: 34673016 DOI: 10.1016/j.bcp.2021.114809] [Reference Citation Analysis]
2 Huang S, Wang Y, Guo J. Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives. Neurosci Bull . [DOI: 10.1007/s12264-022-00836-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zalewska A, Klimiuk A, Zięba S, Wnorowska O, Rusak M, Waszkiewicz N, Szarmach I, Dzierżanowski K, Maciejczyk M. Salivary gland dysfunction and salivary redox imbalance in patients with Alzheimer's disease. Sci Rep 2021;11:23904. [PMID: 34903846 DOI: 10.1038/s41598-021-03456-9] [Reference Citation Analysis]
4 Gong X, Zhang H, Liu X, Liu Y, Liu J, Fapohunda FO, Lü P, Wang K, Tang M. Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease? Front Aging Neurosci 2022;14:977999. [DOI: 10.3389/fnagi.2022.977999] [Reference Citation Analysis]